Abstract 6570: Characterization of diverse extracellular nanoparticles and tumorigenic relevance in hepatocellular carcinoma

Abstract Introduction: Tumor-derived extracellular nanoparticles termed exomeres (EM), distinct to small extracellular vesicles (sEV), act as critical mediators of the tumor microenvironment (TME) formation and are associated with tumor progression and therapy resistance in hepatocellular carcinoma (HCC). Methods: sEV and EM were isolated from various normal and cancer cell lines using serial ultracentrifugation. The physical and biomedical characterization of EM versus sEV was conducted through transmission electron microscopy (TEM) and mass spectrometry (MS) analysis. Potential molecular EM markers were identified based on the distinct proteomic profiles between sEV and EM. The tumorigenic potentials of HCC-EM were evaluated using in vitro functional assays and in vivo mice models. Relevant oncogenic mechanisms were studied according to the differential cargo contents of HCC- and normal-EM, as well as differential gene expression of the recipient cells by RNA sequencing. The effects of EM on cell cycle progression and metabolic dysregulation were investigated by flow cytometry and analytical metabolomic/lipidomic approaches. Results: The TEM and MS analysis demonstrated distinct morphological and protein differences between sEV and EM. GALNS and MAN2B1 were two proteins identified as potential EM markers, showing exclusive or significantly higher expression. Functionally, EM released from HCC cells, instead of normal hepatocytes, stimulated cell growth, motility and tumor development. The EM originated from human HCC cells exhibited increased WNT5A, LRP5, and LRP6 levels, activating the PI3K/AKT/mTOR pathway in recipient cells. In addition, EM derived from murine HCC cells were shown to accelerate cell cycle progression by shifting cells through the checkpoint into the G1 phase, and reconstitute the lipid pattern to be enriched with a very-long chained saturated fatty acid, which triggers the metabolic reprogramming. Conclusions: Collectively, our findings underscore the unique characteristics of EM as a nanoparticle subpopulation that differs from sEV, and that EM derived from HCC can play a significant role in tumorigenesis and metastasis. Citation Format: Jiaqi Lai, Cherlie Lot Yeung, Cui Le, Lavisha Korani, Tung Him Ng, Xiaoxin Zhang, Zhixian Chen, Ruiqi Ma, Chi Ming Che, Judy Wai Yam. Characterization of diverse extracellular nanoparticles and tumorigenic relevance in hepatocellular carcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 6570.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2025-04-21
DOI
https://doi.org/10.1158/1538-7445.am2025-6570
Primary Topic
Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 6570: Characterization of diverse extracellular nanoparticles and tumorigenic relevance in hepatocellular carcinoma

Chi‐Ming Che, Judy Wai Ping Yam, Cherlie Lot Sum Yeung, Jinfeng Lai et al.
Cancer Research
Cancer Research and Treatment
article

Abstract 6570: Characterization of diverse extracellular nanoparticles and tumorigenic relevance in hepatocellular carcinoma

Chi‐Ming Che, Judy Wai Ping Yam, Cherlie Lot Sum Yeung, Jinfeng Lai, Tung Him Ng, Ruiqi Ma, Zhixian Chen, Le Cui, Lavisha Korani, Xiaoxin Zhang
article en

Abstract

Abstract Introduction: Tumor-derived extracellular nanoparticles termed exomeres (EM), distinct to small extracellular vesicles (sEV), act as critical mediators of the tumor microenvironment (TME) formation and are associated with tumor progression and therapy resistance in hepatocellular carcinoma (HCC). Methods: sEV and EM were isolated from various normal and cancer cell lines using serial ultracentrifugation. The physical and biomedical characterization of EM versus sEV was conducted through transmission electron microscopy (TEM) and mass spectrometry (MS) analysis. Potential molecular EM markers were identified based on the distinct proteomic profiles between sEV and EM. The tumorigenic potentials of HCC-EM were evaluated using in vitro functional assays and in vivo mice models. Relevant oncogenic mechanisms were studied according to the differential cargo contents of HCC- and normal-EM, as well as differential gene expression of the recipient cells by RNA sequencing. The effects of EM on cell cycle progression and metabolic dysregulation were investigated by flow cytometry and analytical metabolomic/lipidomic approaches. Results: The TEM and MS analysis demonstrated distinct morphological and protein differences between sEV and EM. GALNS and MAN2B1 were two proteins identified as potential EM markers, showing exclusive or significantly higher expression. Functionally, EM released from HCC cells, instead of normal hepatocytes, stimulated cell growth, motility and tumor development. The EM originated from human HCC cells exhibited increased WNT5A, LRP5, and LRP6 levels, activating the PI3K/AKT/mTOR pathway in recipient cells. In addition, EM derived from murine HCC cells were shown to accelerate cell cycle progression by shifting cells through the checkpoint into the G1 phase, and reconstitute the lipid pattern to be enriched with a very-long chained saturated fatty acid, which triggers the metabolic reprogramming. Conclusions: Collectively, our findings underscore the unique characteristics of EM as a nanoparticle subpopulation that differs from sEV, and that EM derived from HCC can play a significant role in tumorigenesis and metastasis. Citation Format: Jiaqi Lai, Cherlie Lot Yeung, Cui Le, Lavisha Korani, Tung Him Ng, Xiaoxin Zhang, Zhixian Chen, Ruiqi Ma, Chi Ming Che, Judy Wai Yam. Characterization of diverse extracellular nanoparticles and tumorigenic relevance in hepatocellular carcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 6570.

Cancer ResearchVol. 85(8_Supplement_1)
Chinese University of Hong Kong (HK), University of Hong Kong (HK)
Openalex Percentile: Top 88%
Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.